Bacillary dysentery: mechanisms and treatment (Q40103330)

17 September 2017

1 reference

title

Bacillary dysentery: mechanisms and treatment (English)

1 reference

17 September 2017

1 reference

Levine MM

1

1 reference

17 September 2017

publication date

1 May 1982

1 reference

Medical Clinics of North America

17 September 2017

published in

1 reference

17 September 2017

volume

66

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

623-638

1 reference

Inhibition of protein synthesis by Shiga toxin

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Adverse Effect of Lomotil Therapy in Shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Comparison of the effects of enterotoxins of Shigella dysenteriae and Vibrio cholerae on the adenylate cyclase system of the rabbit intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Experimental Shigella infections. VI. Role of the small intestine in an experimental infection in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Virulence of Shigella flexneri Hybrids Expressing Escherichia coli Somatic Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Single-dose ampicillin therapy for severe shigellosis in Bangladesh.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Shigella Infection of Henle Intestinal Epithelial Cells: Role of the Host Cell

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Comparison of intramuscular and oral ampicillin therapy for shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

The Pathogenesis of Shigella Diarrhea. V. Relationship of Shiga Enterotoxin, Neurotoxin, and Cytotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

The Pathogenesis of Shigella Diarrhea. VI. Toxin and Antitoxin in Shigella flexneri and Shigella sonnei Infections in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Pathogenesis of shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving β1 {arrow} 4-linked N-acetyl-D-glucosamine oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Resistance of shigellae to ampicillin and other antibiotics: South Bronx, New York (1971 and 1972)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Shigella and Salmonella Diarrhoeal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Lactulose Therapy in Shigella Carrier State and Acute Dysentery

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Production and characterization of exotoxin(s) of Shigella dysenteriae type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Comparison of trimethoprim-sulfamethoxazole and ampicillin theraphy for shigellosis in ambulatory

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Cinemicrographic study of tissue cell cultures infected with Shigella flexneri

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

A Possible Role of Glycolipids in Epithelial Cell Penetration by VirulentShigella flexneri2a

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Phagocytosis Stimulation by an Extracellular Product of VirulentShigella flexneri2a

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Effect of Calcium on the Cell Infectivity of VirulentShigella flexneri2a

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Divalent cation stimulation of the cell infectivity of Shigella flexneri 2a.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Single-Dose Tetracycline Therapy for Shigellosis in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

On a Dysentery Toxin and Antitoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Clinical and Bacteriological Evaluation of Antibiotic Treatment in Shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

Changing Needs in the Antimicrobial Therapy of Shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931411-0

7 January 2021

10.1016/S0025-7125(16)31411-0

Identifiers

DOI

0 references

1 reference